These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 867500)

  • 21. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alloimmunized, thrombocytopenic patient successfully transfused with acid-treated, random-donor platelets.
    Shanwell A; Sallander S; Olsson I; Gulliksson H; Pedajas I; Lerner R
    Br J Haematol; 1991 Nov; 79(3):462-5. PubMed ID: 1751374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Optimal donor selection and the effectiveness of platelet transfusion in cases refractory to platelet transfusion].
    Iwanaga T; Tsubaki K; Horiuchi A; Fujikawa Y; Kanemitsu Y
    Rinsho Ketsueki; 1986 Jul; 27(7):1274-7. PubMed ID: 3784009
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selection of compatible thrombocyte donors using a solid-phase immunoassay in polytransfused patients].
    Bade L; Gerdes R; Keller E; Rogge T
    Beitr Infusionsther; 1988; 21():299-303. PubMed ID: 2462997
    [No Abstract]   [Full Text] [Related]  

  • 26. [HLA compatibility and survival of 51 chromium-labeled allogeneic thrombocytes].
    Májský A; Fortýnová J; Vopatová M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):831-7. PubMed ID: 6176508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clot: platelet transfusion.
    Chapman R
    Rocky Mt Med J; 1977; 74(3):146-50. PubMed ID: 301288
    [No Abstract]   [Full Text] [Related]  

  • 28. Sounding board: Platelet transfusions from single donors.
    Schiffer CA; Slichter SJ
    N Engl J Med; 1982 Jul; 307(4):245-8. PubMed ID: 7088074
    [No Abstract]   [Full Text] [Related]  

  • 29. The current status of platelet and granulocyte transfusions.
    Seidl S; Kilp M
    Haematologia (Budap); 1980; 13(1-4):145-54. PubMed ID: 7019021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet replacement therapy: a clinical assessment.
    Hester JP; McCredie KB; Freireich EJ
    Prog Clin Biol Res; 1978; 28():281-93. PubMed ID: 752154
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictive value of lymphocytotoxic test and platelet aggregometry for the effect of transfused platelet concentrates.
    Kotelba-Witkowska B; Zupańska B; Brojer E; Daszyński J; Gaczkowski A
    Haematologia (Budap); 1981 Dec; 14(4):375-81. PubMed ID: 7344974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet transfusions to HLA-immunized recipients: how to be or not to be matched.
    Rubinstein P
    Transfusion; 2010 Nov; 50(11):2292-4. PubMed ID: 21182628
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood component transfusion therapy].
    Takahashi K; Juji T
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):897-901. PubMed ID: 1919204
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet transfusion therapy.
    Slichter SJ
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):291-311. PubMed ID: 2179213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfusion of platelets and plasma products.
    Menitove JE; Aster RH
    Clin Haematol; 1983 Feb; 12(1):239-66. PubMed ID: 6340882
    [No Abstract]   [Full Text] [Related]  

  • 36. [Selection of HLA compatible donors for patients with HLA antibodies].
    Májský A; Korínková P; Kubícková Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):937-43. PubMed ID: 2419224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential HLA-matched platelet donor availability for alloimmunized patients.
    Schiffer CA; Keller C; Dutcher JP; Aisner J; Hogge D; Wiernik PH
    Transfusion; 1983; 23(4):286-9. PubMed ID: 6879666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of an appropriate size of unrelated donor pool to be registered for HLA-matched platelet transfusion.
    Takahashi K; Juji T; Miyazaki H
    Transfusion; 1987; 27(5):394-8. PubMed ID: 3477043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controversies in platelet transfusion therapy.
    Slichter SJ
    Annu Rev Med; 1980; 31():509-40. PubMed ID: 6994626
    [No Abstract]   [Full Text] [Related]  

  • 40. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.
    Nambiar A; Duquesnoy RJ; Adams S; Zhao Y; Oblitas J; Leitman S; Stroncek D; Marincola F
    Blood; 2006 Feb; 107(4):1680-7. PubMed ID: 16269623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.